Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Stages of Infection01:26

Stages of Infection

Stages of infection describe what happens to a susceptible host once a pathogen invades the human body. The stages of infection are incubation, prodromal, illness, stage of decline, and convalescence. The incubation stage is the period from exposure to a pathogen until symptoms start. The infected person is unaware of impending illness as the pathogens grow and multiply within the body. The duration may vary depending on the type of infection. The incubation period of measles averages ten to...
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Immunomodulatory role and therapeutic potential of thrombospondin-1 during infectious diseases and autoimmunity.

BMC biology·2026
Same author

Regulation of antiviral immunity by PD-1 during respiratory syncitial virus infection and upon vaccination.

iScience·2026
Same author

Current GMP standards for the large-scale production of monoclonal antibodies.

Bioengineering & translational medicine·2026
Same author

Carbon monoxide-producing probiotic <i>Escherichia coli</i> attenuates HSV-1 skin disease.

iScience·2026
Same author

Change in the distribution of <i>Streptococcus pneumoniae</i> serotypes causing invasive pneumococcal disease among pediatric and adult patients in Chile between 2016 and 2023.

Frontiers in microbiology·2026
Same author

The Expanding Organ Tropism of Herpes Simplex Virus Type 1.

Reviews in medical virology·2026
Same journal

The immunopharmacological role of B-cell and neutrophil-derived extracellular vesicles in pancreatic cancer: Mechanisms of inflammation, tumor progression, and potential therapeutic targets.

International immunopharmacology·2026
Same journal

USP4-mediated deubiquitination of NOTCH1 inhibits HNSCC progression through regulating oxidative stress and ferroptosis.

International immunopharmacology·2026
Same journal

PRDM1 regulates cytokine production in CD4+ T cells and prolongs islet and skin allograft survival by regulating Th1/Th2 differentiation.

International immunopharmacology·2026
Same journal

YWHAZ acts as a regulatory node in Streptococcus pneumoniae-induced pulmonary inflammation.

International immunopharmacology·2026
Same journal

Germacrone promotes diabetic ulcer healing via Hedgehog pathway activation.

International immunopharmacology·2026
Same journal

Exploring potential key genes and mitotic catastrophe-associated correlates in sepsis-induced acute respiratory distress syndrome using transcriptomics and experimental validation.

International immunopharmacology·2026
See all related articles

Related Experiment Video

Updated: Jul 3, 2026

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
09:01

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection

Published on: December 10, 2013

Host immunity during RSV pathogenesis.

Susan M Bueno1, Pablo A González, Rodrigo Pacheco

  • 1Millennium Nucleus on Immunology and Immunotherapy. Departamento de Genética Molecular y Microbiología, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Chile.

International Immunopharmacology
|August 9, 2008
PubMed
Summary
This summary is machine-generated.

Respiratory syncytial virus (RSV) causes severe childhood illness and reinfection due to poor immune memory. This review explores how RSV manipulates the immune system, promoting allergic responses and hindering viral clearance.

More Related Videos

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses
11:48

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses

Published on: April 4, 2019

An Improved and High Throughput Respiratory Syncytial Virus (RSV) Micro-neutralization Assay
09:14

An Improved and High Throughput Respiratory Syncytial Virus (RSV) Micro-neutralization Assay

Published on: January 26, 2019

Related Experiment Videos

Last Updated: Jul 3, 2026

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
09:01

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection

Published on: December 10, 2013

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses
11:48

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses

Published on: April 4, 2019

An Improved and High Throughput Respiratory Syncytial Virus (RSV) Micro-neutralization Assay
09:14

An Improved and High Throughput Respiratory Syncytial Virus (RSV) Micro-neutralization Assay

Published on: January 26, 2019

Area of Science:

  • Immunology
  • Virology
  • Pediatric Infectious Diseases

Background:

  • Respiratory syncytial virus (RSV) is a primary cause of pediatric hospitalization globally, imposing significant health and economic burdens.
  • RSV infection results in inadequate immunological memory, leading to limited protection against reinfection and exacerbating respiratory tract inflammation.
  • The inefficient immune response during RSV infection is often linked to a Th2-biased immunity, promoting allergic-type responses.

Purpose of the Study:

  • To review recent findings on the innate and adaptive immune responses involved in RSV-mediated disease exacerbation.
  • To describe the virulence mechanisms employed by RSV to evade protective immune responses.
  • To elucidate how RSV infection enhances allergic-type immunity, potentially hindering cytotoxic T cell clearance.

Main Methods:

  • Review of current scientific literature and research findings on RSV immunology and pathogenesis.
  • Analysis of molecular mechanisms underlying RSV-induced immune responses and immune evasion strategies.
  • Synthesis of data concerning the role of Th2-biased immunity in RSV disease severity.

Main Results:

  • RSV infection triggers an exacerbated inflammatory response, contributing to airway damage and disease severity.
  • The virus appears to possess mechanisms to induce allergic-type immunity, potentially to evade immune clearance.
  • Inadequate immunological memory following RSV infection facilitates reinfection and recurrent illness.

Conclusions:

  • Understanding the complex interplay between RSV and the host immune system is crucial for developing effective interventions.
  • RSV's ability to modulate immune responses highlights its capacity for immune evasion and persistence.
  • Further research into RSV's virulence factors and immune-modulating strategies is needed to combat its significant global health impact.